{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T17:20:22Z","timestamp":1791566422490,"version":"4.3.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["18K07542"],"award-info":[{"award-number":["18K07542"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.jns.2024.123287","type":"journal-article","created":{"date-parts":[[2024,10,30]],"date-time":"2024-10-30T05:51:26Z","timestamp":1730267486000},"page":"123287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Prevalence and risk surveillance of anti-mitochondrial antibody-positive myositis: Outcomes of a nationwide survey"],"prefix":"10.1016","volume":"467","author":[{"given":"Meiko","family":"Maeda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kawahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akatsuki","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsushi","family":"Toda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2024.123287_bb0005","first-page":"10","article-title":"Biomarkers in inflammatory myopathies\u2014an expanded definition","author":"Benveniste","year":"2019","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.jns.2024.123287_bb0010","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.semarthrit.2017.06.004","article-title":"Inflammatory myopathy associated with anti-mitochondrial antibodies: a distinct phenotype with cardiac involvement","volume":"47","author":"Albayda","year":"2018","journal-title":"Semin. Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.jns.2024.123287_bb0015","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/brain\/aws106","article-title":"Inflammatory myopathies associated with anti-mitochondrial antibodies","volume":"135","author":"Maeda","year":"2012","journal-title":"Brain"},{"issue":"5\u20136","key":"10.1016\/j.jns.2024.123287_bb0020","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000481503","article-title":"Less limb muscle involvement in myositis patients with anti-mitochondrial antibodies","volume":"78","author":"Uenaka","year":"2017","journal-title":"Eur. Neurol."},{"issue":"3","key":"10.1016\/j.jns.2024.123287_bb0025","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jbspin.2017.04.004","article-title":"Anti-mitochondrial antibodies are not a hallmark of severity in idiopathic inflammatory myopathies","volume":"85","author":"Mauhin","year":"2018","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.jns.2024.123287_bb0030","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.nmd.2018.11.004","article-title":"Idiopathic inflammatory myopathies with anti-mitochondrial antibodies: clinical features and treatment outcomes in a Chinese cohort","volume":"29","author":"Hou","year":"2019","journal-title":"Neuromuscul. Disord."},{"issue":"4","key":"10.1016\/j.jns.2024.123287_bb0035","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.semarthrit.2021.05.019","article-title":"Muscle pathological features and extra-muscle involvement in idiopathic inflammatory myopathies with anti-mitochondrial antibody","volume":"51","author":"Zhang","year":"2021","journal-title":"Semin. Arthritis Rheum."},{"issue":"10","key":"10.1016\/j.jns.2024.123287_bb0040","doi-asserted-by":"crossref","first-page":"4095","DOI":"10.1007\/s10067-021-05730-7","article-title":"Anti-mitochondrial autoantibodies are associated with cardiomyopathy, dysphagia, and features of more severe disease in adult-onset myositis","volume":"40","author":"Sabbagh","year":"2021","journal-title":"Clin. Rheumatol."},{"issue":"6","key":"10.1016\/j.jns.2024.123287_bb0045","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/1756-185X.14320","article-title":"Anti-mitochondrial antibodies in Indian patients with idiopathic inflammatory myopathies","volume":"25","author":"Gaur","year":"2022","journal-title":"Int. J. Rheum. Dis."},{"key":"10.1016\/j.jns.2024.123287_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2022.120391","article-title":"Clinical features of anti-mitochondrial M2 antibody-positive myositis: case series of 17 patients","volume":"442","author":"Nagai","year":"2022","journal-title":"J. Neurol. Sci."},{"issue":"11","key":"10.1016\/j.jns.2024.123287_bb0055","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1002\/acn3.51901","article-title":"Clinicopathological and circulating cell-free DNA profile in myositis associated with anti-mitochondrial antibody","volume":"10","author":"Wang","year":"2023","journal-title":"Ann. Clin. Transl. Neurol."},{"issue":"5","key":"10.1016\/j.jns.2024.123287_bb0060","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10\u201312 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscul. Disord."},{"issue":"1","key":"10.1016\/j.jns.2024.123287_bb0065","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.nmd.2019.10.005","article-title":"239th ENMC international workshop: classification of dermatomyositis, Amsterdam, the Netherlands, 14\u201316 December 2018","volume":"30","author":"Mammen","year":"2020","journal-title":"Neuromuscul. Disord."},{"issue":"2","key":"10.1016\/j.jns.2024.123287_bb0070","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2017-000507","article-title":"EULAR\/ACR classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups: a methodology report","volume":"3","author":"Bottai","year":"2017","journal-title":"RMD Open"},{"issue":"1","key":"10.1016\/j.jns.2024.123287_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/14397595.2018.1521185","article-title":"Treatment consensus for management of polymyositis and dermatomyositis among rheumatologists, neurologists and dermatologists","volume":"29","author":"Kohsaka","year":"2018","journal-title":"Mod. Rheumatol."},{"issue":"11","key":"10.1016\/j.jns.2024.123287_bb0080","first-page":"880","article-title":"A method of interval estimation for number of patients in the nationwide epidemiological survey on intractable diseases","volume":"38","author":"Hashimoto","year":"1991","journal-title":"Nihon Koshu Eisei Zasshi"},{"key":"10.1016\/j.jns.2024.123287_bb0085","series-title":"Clinical Prediction Models: A Practical Approach to Development, Validation, and Updating","author":"Steyerberg","year":"2019"},{"issue":"8","key":"10.1016\/j.jns.2024.123287_bb0090","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.1093\/rheumatology\/keaa872","article-title":"Ventricular arrhythmia predicts poor outcome in polymyositis\/dermatomyositis with myocardial involvement","volume":"60","author":"Huang","year":"2021","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.jns.2024.123287_bb0095","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/CRD.0000000000000241","article-title":"Cardiac manifestations in idiopathic inflammatory myopathies","volume":"27","author":"Jayakumar","year":"2019","journal-title":"Cardiol. Rev."},{"issue":"1","key":"10.1016\/j.jns.2024.123287_bb0100","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.md.0000109755.65914.5e","article-title":"Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features","volume":"83","author":"Dank\u00f3","year":"2004","journal-title":"Medicine"},{"issue":"136","key":"10.1016\/j.jns.2024.123287_bb0105","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1183\/16000617.00002015","article-title":"Idiopathic inflammatory myopathies and the lung","volume":"24","author":"Lega","year":"2015","journal-title":"Eur. Respir. Rev."},{"issue":"3","key":"10.1016\/j.jns.2024.123287_bb0110","doi-asserted-by":"crossref","DOI":"10.1093\/omcr\/omaa150","article-title":"Cardiac arrest in anti-mitochondrial antibody associated inflammatory myopathy","volume":"2021","author":"H\u00f8jgaard","year":"2021","journal-title":"Oxf. Med. Case Rep."},{"issue":"12","key":"10.1016\/j.jns.2024.123287_bb0115","article-title":"Life-threatening ventricular arrhythmia and left ventricular dysfunction associated with anti-mitochondrial antibody-positive myositis: a case report","volume":"5","author":"Hasegawa","year":"2021","journal-title":"Eur. Heart J. Case Rep."},{"issue":"10","key":"10.1016\/j.jns.2024.123287_bb0120","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000008062","article-title":"Prevalence, clinical profiles, and prognosis of POEMS syndrome in Japanese nationwide survey","volume":"93","author":"Suichi","year":"2019","journal-title":"Neurology"},{"issue":"7","key":"10.1016\/j.jns.2024.123287_bb0125","first-page":"694","article-title":"Polymyositis with marked paravertebral muscle atrophy in patients with primary biliary cirrhosis","volume":"40","author":"Matsui","year":"2000","journal-title":"Rinsho Shinkeigaku"},{"issue":"4\u20135","key":"10.1016\/j.jns.2024.123287_bb0130","first-page":"280","article-title":"A case with severe respiratory muscle weakness due to chronic myositis associated with PBC","volume":"44","author":"Kasuga","year":"2004","journal-title":"Rinsho Shinkeigaku"},{"issue":"23","key":"10.1016\/j.jns.2024.123287_bb0135","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.2169\/internalmedicine.7448-21","article-title":"Inflammatory myopathy associated with anti-mitochondrial antibody presenting only with respiratory failure","volume":"60","author":"Fujii","year":"2021","journal-title":"Intern. Med."},{"issue":"1","key":"10.1016\/j.jns.2024.123287_bb0140","doi-asserted-by":"crossref","first-page":"097","DOI":"10.1055\/s-2003-40757","article-title":"Warning signs of imminent respiratory failure in neurological patients","volume":"23","author":"Rabinstein","year":"2003","journal-title":"Semin. Neurol."},{"issue":"6","key":"10.1016\/j.jns.2024.123287_bb0145","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1002\/ehf2.12984","article-title":"Cardiac involvement with anti-mitochondrial antibody-positive myositis mimicking cardiac sarcoidosis","volume":"7","author":"Kadosaka","year":"2020","journal-title":"ESC Heart Fail."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24004234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X24004234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T09:23:46Z","timestamp":1733909026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X24004234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":29,"alternative-id":["S0022510X24004234"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2024.123287","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and risk surveillance of anti-mitochondrial antibody-positive myositis: Outcomes of a nationwide survey","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2024.123287","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"123287"}}